SCHEMBL11029136

SCHEMBL11029136

O=C1Nc2ccccc2C1=C1C(=O)Nc2ccc(F)cc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 3/20 0.54
LRRK2 Q5S007 6/20 0.51
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
AGTR1 P30556 1/20 0.50
KDR P35968 1/20 0.50
ACVR1 Q04771 2/20 0.48
MAOA P21397 2/20 0.48
MAOB P27338 2/20 0.48
PDGFRA P16234 1/20 0.48
FER P16591 1/20 0.48
LTK P29376 1/20 0.48
CDK8 P49336 1/20 0.48
DYRK1B Q9Y463 1/20 0.48
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CSNK1G1 Q9HCP0 1/20 0.45
CHEK1 O14757 1/20 0.45
RPS6KA3 P51812 1/20 0.45
EGFR P00533 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11890574 1.00 FLT3 (0.54) FLT3LRRK2KMT2AMEN1AGTR1
SCHEMBL31491093 0.90 LRRK2 (0.50) FLT3LRRK2KMT2AMEN1AGTR1
SCHEMBL16583648 0.86 FLT3 (0.48) FLT3LRRK2KMT2AMEN1AGTR1
SCHEMBL21480103 0.86 MAOA (0.50) FLT3LRRK2KMT2AMEN1AGTR1
SCHEMBL3848509 0.86 MAOA (0.50) FLT3LRRK2KMT2AMEN1AGTR1
SCHEMBL2589272 0.83 LRRK2 (0.57) LRRK2KMT2AMEN1KDRACVR1
SCHEMBL2589274 0.83 LRRK2 (0.57) LRRK2KMT2AMEN1KDRACVR1
Isoindigo SCHEMBL9899736 0.83 LRRK2 (0.67) LRRK2KDRACVR1MAOAMAOB
Isoindigo SCHEMBL9899740 0.83 LRRK2 (0.67) LRRK2KDRACVR1MAOAMAOB
Isoindigo SCHEMBL12386233 0.83 LRRK2 (0.67) LRRK2KDRACVR1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120190009-A1 Viral Modulators and Processes Thereof KASHANCHI FATAH (US) 2012-07-26 US disclosed
US-20120190723-A1 VIRAL MODULATORS AND PROCESSES THEREOF KASHANCHI FATAH (US) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190723-A1 VIRAL MODULATORS AND PROCESSES THEREOF MAVS, HAVCR2, HDLBP FLT3 3367/4885LRRK2 3338/4885KMT2A 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.